All posts by: Michael Zand

About Michael Zand

CAR T-Cell Therapies for Hematologic Malignancies Moving Toward the Clinic – Targeted Oncology

Continue reading

2017-08-16 NEWS

CAR T-Cell Therapies for Hematologic Malignancies Moving Toward the Clinic
Targeted Oncology
Updated results from ZUMA-3, a phase 1/2 study of KTE-C19 chimeric antigen receptor (CAR) T cell therapy, in adults with high-burden relapsed/refrac- tory acute lymphoblastic leukemia (R/R ALL). J Clin Oncol. 2017;35(suppl; abstr 3024). Locke FL …
Global CAR T Cell Therapy Market, By Targeted Antigen, Therapeutic Application, and Geography – Trends, Analysis …Medgadget (blog)

all 2 news articles »

Continue reading

2017-08-16 NEWS

Pfizer to expand in Sanford for genetherapy medications
Palmetto Business Daily
Gene therapy focuses on specialized, one-time treatments to address diseases caused by genetic mutation. In gene therapy, new genetic material is introduced into the body to correct a patient’s cells as needed. “Pfizer is proud to further expand our

Continue reading

2017-08-16 NEWS

NewsWest9.com

Stem cell pain management treatment aimed to stop chronic pain forever
NewsWest9.com
If you’re experiencing chronic pain and it’s preventing you from doing the things you love, Medical Center Hospital is offering stem cell pain management treatment. A doctor performed the procedure on a patient on Tuesday. The patient, Donna Duree